Sunitinib Capsules: Essential Guide To Dosage & Side Effects
Comprehensive guide to Sunitinib capsules for treating GIST, renal cell carcinoma, and pancreatic neuroendocrine tumors.
Sunitinib, marketed as Sutent, is a targeted oral medication that inhibits multiple kinases involved in tumor growth and angiogenesis, used primarily for treating specific advanced cancers including gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (MRCC), and pancreatic neuroendocrine tumors (pNET).
About Sunitinib Capsules
Sunitinib malate capsules work by blocking enzymes called tyrosine kinases, which play key roles in the growth and spread of cancer cells. It targets vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs), thereby starving tumors of blood supply and halting proliferation. This multi-targeted approach makes it effective for cancers resistant to other therapies.
Available in strengths such as 12.5 mg, 25 mg, 37.5 mg, and 50 mg capsules, Sutent is taken orally, with or without food, offering convenience for patients undergoing long-term treatment cycles.
Key Uses
- Gastrointestinal Stromal Tumor (GIST): For adults after disease progression on or intolerance to imatinib mesylate.
- Metastatic Renal Cell Carcinoma (MRCC): As adjuvant treatment following nephrectomy or for advanced cases.
- Pancreatic Neuroendocrine Tumors (pNET): Unresectable or progressive disease in adults.
Before Taking Sunitinib
Consult your doctor if you have heart conditions, high blood pressure, liver or kidney issues, bleeding disorders, diabetes, thyroid problems, seizures, or dental issues. Inform about all medications, as interactions can occur with CYP3A4 inhibitors/inducers like ketoconazole or rifampin. Not recommended for children under 18 or pregnant/breastfeeding women due to potential fetal harm.
| Condition | Precautions |
|---|---|
| Heart disease or hypertension | Monitor blood pressure; risk of heart failure or QT prolongation. |
| Liver impairment | May cause severe liver damage; regular tests needed. |
| Diabetes | Monitor blood sugar closely; dose adjustments for antidiabetics may be required. |
| Bleeding risks | Increased chance of hemorrhage, including GI or tumor bleeding. |
How to Take Sunitinib
Swallow capsules whole with water, once daily at the same time, with or without food. Do not crush or open. If a dose is missed by less than 12 hours, take it immediately; otherwise, skip and resume schedule. Do not double dose.
Dosing Schedules
- GIST or MRCC: 50 mg once daily for 4 weeks (28 days), followed by 2 weeks off, repeating in 6-week cycles until progression or toxicity.
- Adjuvant RCC (post-nephrectomy): 50 mg once daily on 4/2 schedule for nine 6-week cycles (about 1 year).
- pNET: 37.5 mg once daily continuously, without rest periods, until progression or unacceptable toxicity. Dose may adjust up to 50 mg or down based on tolerance.
Dose reductions (e.g., to 37.5 mg or 25 mg) occur for toxicities like hypertension, hand-foot syndrome, or cytopenias. Your doctor will monitor via blood tests and adjust accordingly.
Common Side Effects
Most patients experience side effects, often manageable with supportive care. Monitor for changes and report severe symptoms immediately.
- Very Common (up to 1 in 10): Fatigue, diarrhea, nausea, vomiting, stomach pain, mouth sores, taste changes, high blood pressure, bleeding, hand-foot skin reaction (redness, pain on palms/soles), low blood counts (thrombocytopenia, neutropenia, anemia).
- Common: Hair color changes, dizziness, headache, cough, infections, hypothyroidism, weight loss, proteinuria.
Serious Side Effects
Seek immediate medical help for:
- Heart issues: Chest pain, shortness of breath, palpitations (risk of heart failure, arrhythmias).
- Liver damage: Yellowing skin/eyes, dark urine.
- Severe bleeding: Black stools, coughing blood, severe headache.
- Hypertension crisis: Severe headache, blurred vision.
- Thrombotic microangiopathy (TMA)/TTP-HUS: Bruising, confusion, reduced urine.
- Other: Seizures, posterior reversible encephalopathy syndrome (PRES), osteonecrosis of jaw, severe skin reactions, tumor lysis syndrome.
Handling and Storage
Store at room temperature (20-25°C), away from moisture and light. Handle capsules carefully to avoid skin contact with powder. Dispose of unused medication properly; do not flush.
Managing Side Effects
- Hand-Foot Reaction: Use moisturizers, avoid hot water/friction; dose interrupt if severe.
- Mouth Sores: Oral rinses, soft foods, good hygiene.
- Diarrhea/Nausea: Antidiarrheals, antiemetics as prescribed.
- Hypertension: Blood pressure meds; hold Sutent if uncontrolled.
- Blood Counts: Regular CBC monitoring; delay/reduce dose for cytopenias.
Regular monitoring includes blood pressure, thyroid function, liver/kidney tests, ECG for QT prolongation, dental exams, and urine protein.
Interactions
Sunitinib interacts with drugs affecting CYP3A4 (e.g., grapefruit juice increases levels; St. John’s wort decreases). Avoid live vaccines. Inform your doctor of all supplements/herbs.
Pregnancy and Fertility
Contraindicated in pregnancy (Category D); use effective contraception during and for 8 weeks after treatment in women, 7 weeks in men. May impair fertility.
Driving and Activities
May cause dizziness or fatigue; avoid driving or operating machinery if affected.
Overdose
Symptoms include worsening side effects. Seek emergency care; no specific antidote.
Frequently Asked Questions (FAQs)
What cancers does Sunitinib treat?
Sunitinib treats GIST after imatinib failure, advanced renal cell carcinoma, and progressive pNET.
Can I take Sunitinib with food?
Yes, with or without food, but consistently to maintain steady levels.
How long do treatment cycles last?
For GIST/MRCC: 4 weeks on, 2 weeks off; pNET: continuous daily dosing.
What if I miss a dose?
Take if <12 hours late; otherwise, skip and continue schedule.
Does Sunitinib cause hair loss?
Hair color may change (depigmentation), but not typical hair loss.
Is monitoring required during treatment?
Yes, frequent blood tests, BP checks, thyroid, liver function, and ECG.
When Not to Use Sunitinib
Avoid if allergic to sunitinib, severe liver impairment without monitoring, uncontrolled hypertension, or recent hemorrhagic events. Use caution in elderly or those with cardiac risks.
References
- Sunitinib Malate Capsules – Pfizer Labeling — Pfizer. 2023. https://labeling.pfizer.com/ShowLabeling.aspx?id=16260
- SUTENT Dosing Information — Pfizer Pro. Accessed 2025. https://sutent.pfizerpro.com/dosing/recommended-dosing
- Sunitinib: MedlinePlus Drug Information — U.S. National Library of Medicine. Updated 2024-10-01. https://medlineplus.gov/druginfo/meds/a607052.html
- Sunitinib (oral route) – Mayo Clinic — Mayo Clinic. Updated 2024. https://www.mayoclinic.org/drugs-supplements/sunitinib-oral-route/description/drg-20070841
- Sunitinib Capsules: Cleveland Clinic — Cleveland Clinic. Updated 2024. https://my.clevelandclinic.org/health/drugs/20289-sunitinib-capsules
- Sunitinib (Sutent®) – OncoLink — OncoLink (Univ. Pennsylvania). Updated 2024. https://www.oncolink.org/cancer-treatment/oncolink-rx/sunitinib-sutent-R
- SUTENT Medication Guide – FDA — U.S. Food and Drug Administration. 2012 (authoritative label). https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021938s019s020mg.pdf
Similar Articles
Read full bio of medha deb
